REVIEW

HPV infections and tonsillar carcinoma

S Syrjänen

Correspondence to:
Correspondence to:
Professor S Syrjänen
Department of Oral Pathology, Institute of Dentistry, Faculty of Medicine, University of Turku, Lemminkäisenkatu 2, FIN-20520 Turku, Finland; stina.syrjanen{at}utu.fi

Since human papillomavirus (HPV) was first linked to laryngeal/oral carcinomas in 1983, several studies have confirmed its causal role in a subgroup of upper aerodigestive tract tumours. Of the non-genital cancers, tonsillar carcinomas (TCs) have the strongest association with HPV. By the end of 2002, 432 TCs had been analysed for HPV DNA. Overall detection rate was 51%, with HPV-16 being the most prevalent (84%). The original proposal that HPV-33 would be the most frequent HPV in TCs has not been confirmed, being present in only 4.6% of cases. HPV copy numbers are similar to those found in genital carcinomas (10–300 copies/cell), although HPV is mainly episomal in TC. The importance of this observation is unclear, although a role for subepithelial proliferative lymphatic tissue has been speculated. Patients with HPV-16 positive tumours have better overall and disease specific survival than HPV negative patients. They are also younger and the association with conventional risk factors—smoking and drinking—is less significant than in HPV negative patients. Thus, recent data suggest a distinct pattern for HPV-16 positive TCs.

Abbreviations: CI, confidence interval; HPV, human papillomavirus; ICD, international classification of diseases; ORF, open reading frame; SCC, squamous cell carcinoma

Keywords: human papillomavirus; tonsil cancer; tonsillar; tonsillar carcinoma; tonsils

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Ernster, J. A., Sciotto, C. G., O'Brien, M. M., Robinson, L. J., Willson, T. (2009). Prevalence of Oncogenic Human Papillomavirus 16 and 18 in the Palatine Tonsils of the General Adult Population. Arch Otolaryngol Head Neck Surg 135: 554-557 [Abstract] [Full Text]  
• Syrjanen, S. (2007). Human Papillomaviruses in Head and Neck Carcinomas. NEJM 356: 1993-1995 [Full Text]  
• Perez-Ordonez, B, Beauchemin, M, Jordan, R C K (2006). Molecular biology of squamous cell carcinoma of the head and neck.. J. Clin. Pathol. 59: 445-453 [Abstract] [Full Text]  
• Laurie, S. A., Bell, J. C., Atkins, H. L., Roach, J., Bamat, M. K., O'Neil, J. D., Roberts, M. S., Groene, W. S., Lorence, R. M. (2006). A Phase 1 Clinical Study of Intravenous Administration of PV701, an Oncolytic Virus, Using Two-Step Desensitization. Clin. Cancer Res. 12: 2555-2562 [Abstract] [Full Text]  
• Chen, R., Sehr, P., Waterboer, T., Leivo, I., Pawlita, M., Vaheri, A., Aaltonen, L.-M. (2005). Presence of DNA of Human Papillomavirus 16 but No Other Types in Tumor-Free Tonsillar Tissue. J. Clin. Microbiol. 43: 1408-1410 [Abstract] [Full Text]